- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to compare the efficacy and safety of vardenafil ODT 10 mg (PRN) after 12 weeks of treatment or LOCF with placebo in a general population of men with erectile dysfunction. In this study, 50% of the men on active treatment have to be 65 years-of-age or older. Primary efficacy variables are: - IIEF-EF Domain score at visit 4 (week 12) or LOCF - SEP 2 (success rates of penetration) and SEP 3 (maintenance of erection) at visit 4 (week 12) overall (co-primary variable)
Critère d'inclusion
- Erectile Dysfunction (ED)